The in vitro alkaline comet assay with liver models as a complementary tool for genotoxicity assessment of N-nitrosamines
Open Access
- 2 June 2026
- journal article
- Published by Springer Nature in Archives of Toxicology
- Vol. 100 (10) , 4717-4736
Abstract
N -nitrosamine (NA) impurities in pharmaceuticals represent “cohort of concern” compounds under ICH M7(R2), due to their mutagenic/carcinogenic potential, involving cytochrome P450 (CYP)-mediated metabolic activation. Increasing interest in mammalian cell-based genotoxicity/mutagenicity assays prompted our assessment of the in vitro alkaline comet assay regarding its predictive power for NAs. Here, precision-cut liver slices (PCLiS), primary human hepatocytes (PHH), primary rat hepatocytes (PRH), and HepG2 cells with rat or hamster S9-mix were investigated as in vitro model systems. Metabolic competence was characterized beforehand. For performance evaluation, a panel of known-mutagenic [ N -nitroso-dimethylamine (NDMA), N -nitroso-diethanolamine, N -nitroso-methylaniline, S – N -nitroso-nornicotine, N-methyl-N-nitroso-2-propanamine] and reported non-mutagenic (methyl-t-butylnitrosamine, N -nitrosoproline) was tested, together with Nitrosamine Drug Substance-Related Impurities [ N -nitrosodesloratadine, N -nitrosofolic acid, N -nitrosofluoxetine (NFluo)] at a concentration range of 0.005–10 mM. After 2 h (PCLiS, PHH and PRH) or 4 h (HepG2), NDMA concentration-dependently induced DNA strand breaks in all in vitro models. Sensitivity/specificity of the various liver cell models for prediction of carcinogenic NAs were 100%/50% (HepG2 with hamster S9-mix), 50%/100% (PHH, PRH), and 50%/50% (HepG2 with rat S9-mix), respectively. Benchmark dose modeling indicated a higher relative in vitro comet assay response for NFluo compared to NDMA in all cell systems. In conclusion, the in vitro comet assay represents a sensitive and/or specific tool for complementing regulatory in vitro tests in prediction of mutagenic NAs. However, further optimization work is needed, using expanded training sets of compounds and thorough validation of liver cell models, before the in vitro comet assay could be incorporated in the standard battery for genotoxicity testing.Keywords
Funding Information
- Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM
This publication has 86 references indexed in Scilit:
- Quantitative in vitro to in vivo extrapolation of genotoxicity data provides protective estimates of in vivo doseEnvironmental and Molecular Mutagenesis, 2022
- Analyzing the Effects of HDAC Inhibitors on DNA Damage and Associated Cytotoxicity in Primary Hepatocytes2022
- Permitted daily exposure limits for noteworthy N‐nitrosaminesEnvironmental and Molecular Mutagenesis, 2021
- Quantitative Interpretation of Genetic Toxicity Dose‐Response Data for Risk Assessment and Regulatory Decision‐Making: Current Status and Emerging PrioritiesEnvironmental and Molecular Mutagenesis, 2019
- Mutation as a Toxicological Endpoint for Regulatory Decision‐MakingEnvironmental and Molecular Mutagenesis, 2019
- ggplot22016
- Targeting O 6-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapyCellular and Molecular Life Sciences, 2010
- High variability of nitrosamine metabolism among individuals: Role of cytochromes P450 2A6 and 2E1 in the dealkylation of N‐nitrosodimethylamine and N‐nitrosodiethylamine in mice and humansMolecular Carcinogenesis, 1993
- Comparison of S9 mix and hepatocytes as external metabolizing systems in Mammalian cell cultures: Cytogenetic effects of 7,12-dimethylbenzanthracene and aflatoxin B1Environmental Mutagenesis, 1986
- Organotrope carcinogene Wirkungen bei 65 verschiedenen N-Nitroso-Verbindungen an BD-RattenJournal of Cancer Research and Clinical Oncology, 1967